EcoDrugPlus

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSSMAG00000001138
Gene Symbol: INPP5D
2 Cross references
215 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSSMAG00000015526
Gene Symbol: INSRA
3 Cross references
212 Possible Orthologues:

Insulin Receptor B

Ensembl ID : ENSSMAG00000004638
Gene Symbol: INSRB
3 Cross references
212 Possible Orthologues:

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSSMAG00000002101
Gene Symbol: IGF1RA
1 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSSMAG00000010426
Gene Symbol: IGF1RB
2 Cross references
203 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSSMAG00000017641
Gene Symbol: LOC118309646
2 Cross references
197 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSSMAG00000009733
Gene Symbol: ITGB3A
1 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSSMAG00000004629
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSSMAG00000007032
Gene Symbol: ITGB1
1 Cross references
228 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSSMAG00000012672
Gene Symbol: ITGB6
1 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSSMAG00000011367
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSSMAG00000020785
Gene Symbol: ITGA5
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).